Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07531888Not ApplicableEnrolling By Invitation

Effects of tDCS on Cognitive Function in Older Adults With Subjective Cognitive Decline: Randomized Sham-Controlled Trial

Role: lead

NCT07359729Not ApplicableCompleted

Deep Breathing and Virtual Reality for Venipuncture Pain

Role: lead

NCT07017296Not ApplicableCompleted

Microencapsulated Pomegranate Juice as Anti-Hypertensive

Role: lead

NCT03531749Not ApplicableCompleted

Antioxidant in Patients HIV+ Supplemented With Microencapsulated of Red Pomegranate

Role: lead

All 4 trials loaded